S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda

Akili (AKLI) Earnings Date, Estimates & Call Transcripts

$0.24
+0.01 (+4.39%)
(As of 04/19/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 10Estimated
Actual EPS
(Feb. 29)
-$0.14 Beat By $0.12
Consensus EPS
(Feb. 29)
-$0.26
Skip Charts & View Estimated and Actual Earnings Data

AKLI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AKLI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Akili Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.25)($0.25)($0.25)
Q2 20241($0.19)($0.19)($0.19)
Q3 20241($0.20)($0.20)($0.20)
Q4 20241($0.17)($0.17)($0.17)
FY 20244($0.81)($0.81)($0.81)
Q1 20251($0.23)($0.23)($0.23)
Q2 20251($0.18)($0.18)($0.18)

AKLI Earnings Date and Information

Akili last issued its earnings results on February 29th, 2024. The reported ($0.14) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.26) by $0.12. The business had revenue of $0.75 million for the quarter, compared to the consensus estimate of $1.07 million. Akili has generated ($0.76) earnings per share over the last year (($0.76) diluted earnings per share). Earnings for Akili are expected to grow in the coming year, from ($0.53) to ($0.28) per share. Akili has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off prior year's report dates.

Akili Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/10/2024
Estimated)
------- 
2/29/2024Q4 2023($0.26)($0.14)+$0.12($0.14)$1.07 million$0.75 million
11/9/2023Q3 2023($0.22)($0.20)+$0.02($0.20)$0.22 million$0.70 million
8/10/2023Q2 2023($0.20)($0.18)+$0.02($0.21)-$0.11 million
5/11/2023Q1 2023($0.18)($0.22)($0.04)($0.17)-$0.11 million  
3/7/2023Q4 2022($0.28)($0.62)($0.34)($0.76)$0.19 million$0.11 million
11/14/2022Q3 2022($0.20)($0.31)($0.11)($1.38)-$0.08 million

Akili Earnings - Frequently Asked Questions

When is Akili's earnings date?

Akili has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off last year's report dates. Learn more on AKLI's earnings history.

Did Akili beat their earnings estimates last quarter?

In the previous quarter, Akili (NASDAQ:AKLI) reported ($0.14) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.26) by $0.12. Learn more on analysts' earnings estimate vs. AKLI's actual earnings.

How much revenue does Akili generate each year?

Akili (NASDAQ:AKLI) has a recorded annual revenue of $1.68 million.

How much profit does Akili generate each year?

Akili (NASDAQ:AKLI) has a recorded net income of -$59.49 million. AKLI has generated -$0.76 earnings per share over the last four quarters.

What is Akili's EPS forecast for next year?

Akili's earnings are expected to grow from ($0.53) per share to ($0.28) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:AKLI) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners